CD4 and asthma: The findings suggest that SLIT for asthma patients with SAR-JCP contributed to the further stabilization of asthma symptoms, and changes in peripheral blood CD27-negative CD4+ T cells, γδ T cells, ILC1s, and ILC3s during the off-season were associated with improved asthma symptoms after SLIT.